Skip to Content

Felbamate Pregnancy and Breastfeeding Warnings

Felbamate is also known as: Felbatol

Felbamate Pregnancy Warnings

Placental transfer of this drug occurs in animal studies. The incidence of malformations was not increased compared to control in offspring of animals given doses several times higher than the therapeutic human daily dose on a mg/kg basis. There are no controlled data in human pregnancy. It is not known whether this drug can cause fetal harm or adversely affect reproductive capacity in humans. To provide information regarding the effects of in utero exposure to this drug, physicians are advised to recommend that pregnant patients enroll in the NAAED Pregnancy Registry. This can be done by calling the toll free number 1-888-233-2334, and must be done by patients themselves. Information on the registry can also be found at the website US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if the benefit outweighs the risk. US FDA pregnancy category: C

See references

Felbamate Breastfeeding Warnings

Use is not recommended. Excreted into human milk: Yes Comment: -The effect in the nursing infant is unknown.

Because no information is available on the use of this drug during breastfeeding, and because it can potentially cause fatal hematologic and hepatic toxicities, most experts recommend that mothers do not breastfeed during therapy.

See references

References for pregnancy information

  1. "Product Information. Felbamate (felbamate)." Amneal Pharmaceuticals, Glasgow, KY.

References for breastfeeding information

  1. "Product Information. Felbamate (felbamate)." Amneal Pharmaceuticals, Glasgow, KY.
  2. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL:" ([cited 2013 -]):

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.